Immunome Inc. — Director's Dealing 2021

Sep 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2021-09-09

Reporting Person: RAPP MICHAEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-09	Common Stock	P	8170	$17.44	Acquired	145000	Indirect
2021-09-09	Common Stock	P	22280	$18.46	Acquired	167280	Indirect
2021-09-10	Common Stock	P	15500	$17.85	Acquired	182780	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	799866	Direct

Footnotes

F1: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $16.76 to $17.65, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

F2: The shares are held by Broadband Capital Investments LLC ("Broadband"). The reporting person is managing member of Broadband and has voting and investment power with respect to shares held by Broadband.

F3: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $17.88 to $18.75, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

F4: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $17.25 to $18.08, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.